210 related articles for article (PubMed ID: 31201905)
1. Hybrid Nanostructured Films for Topical Administration of Simvastatin as Coadjuvant Treatment of Melanoma.
Barone A; Mendes M; Cabral C; Mare R; Paolino D; Vitorino C
J Pharm Sci; 2019 Oct; 108(10):3396-3407. PubMed ID: 31201905
[TBL] [Abstract][Full Text] [Related]
2. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
3. Expanding Transdermal Delivery with Lipid Nanoparticles: A New Drug-in-NLC-in-Adhesive Design.
Mendes M; Nunes SCC; Sousa JJ; Pais AACC; Vitorino C
Mol Pharm; 2017 Jun; 14(6):2099-2115. PubMed ID: 28475834
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
6. Nanostructuring lipid carriers using Ridolfia segetum (L.) Moris essential oil.
Miranda M; Cruz MT; Vitorino C; Cabral C
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109804. PubMed ID: 31349527
[TBL] [Abstract][Full Text] [Related]
7. Topotecan-loaded lipid nanoparticles as a viable tool for the topical treatment of skin cancers.
Venâncio JH; Andrade LM; Esteves NLS; Brito LB; Valadares MC; Oliveira GAR; Lima EM; Marreto RN; Gratieri T; Taveira SF
J Pharm Pharmacol; 2017 Oct; 69(10):1318-1326. PubMed ID: 28703281
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
Safwat S; Ishak RAH; Hathout RM; Mortada ND
Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784
[TBL] [Abstract][Full Text] [Related]
9. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
Zhao X; Sun Y; Li Z
Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes.
Na YG; Huh HW; Kim MK; Byeon JJ; Han MG; Lee HK; Cho CW
Acta Biomater; 2020 Jan; 101():507-518. PubMed ID: 31629894
[TBL] [Abstract][Full Text] [Related]
12. Can lipid nanoparticles improve intestinal absorption?
Mendes M; Soares HT; Arnaut LG; Sousa JJ; Pais AACC; Vitorino C
Int J Pharm; 2016 Dec; 515(1-2):69-83. PubMed ID: 27667757
[TBL] [Abstract][Full Text] [Related]
13. Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea.
Shinde UA; Parmar SJ; Easwaran S
Drug Dev Ind Pharm; 2019 Jul; 45(7):1039-1051. PubMed ID: 30727789
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
Rajinikanth PS; Chellian J
Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
[TBL] [Abstract][Full Text] [Related]
15. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Mennini N; Cirri M; Maestrelli F; Mura P
Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
[TBL] [Abstract][Full Text] [Related]
16. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin-loaded nanostructured lipid carriers attenuate the atherogenic risk of erythrocytes in hyperlipidemic rats.
Harisa GI; Alomrani AH; Badran MM
Eur J Pharm Sci; 2017 Jan; 96():62-71. PubMed ID: 27613383
[TBL] [Abstract][Full Text] [Related]
18. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
19. Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail.
Vitorino C; Almeida J; Gonçalves LM; Almeida AJ; Sousa JJ; Pais AA
J Control Release; 2013 May; 167(3):301-14. PubMed ID: 23454133
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers for site-specific drug delivery.
Khosa A; Reddi S; Saha RN
Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
